Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

Published-on by Indian Scientist

Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

IFTM University, Moradabad, India

Akash Vikal is an emerging pharmaceutical researcher specializing in pharmaceutics, nanomedicine, advanced drug delivery systems, and cancer therapeutics. His academic and research contributions primarily focus on the development of innovative formulation strategies designed to improve therapeutic efficacy, targeted delivery, and patient outcomes. Through extensive research in liposomal formulations, nanocarriers, gene delivery systems, and ocular therapeutics, he has established himself as a promising young contributor to modern pharmaceutical sciences.His research portfolio reflects interdisciplinary expertise integrating pharmaceutical technology, nanotechnology, oncology, ophthalmic therapeutics, and translational medicine. With numerous peer-reviewed publications, book chapters, and scientific presentations, he has actively contributed to advancing pharmaceutical innovation and drug delivery research.

Professional Profile 

Education

Akash Vikal completed a Bachelor of Pharmacy (B.Pharm.) from Shri Gopichand College of Pharmacy with strong academic performance. He further pursued a Master of Pharmacy (M.Pharm.) in Pharmaceutics from ISF College of Pharmacy, where he specialized in advanced pharmaceutical formulation and drug delivery systems. His postgraduate research focused on the “Development and Characterization of Ferulic Acid and Docetaxel Loaded Liposomes Against Breast Cancer” under the guidance of Balak Das Kurmi.

Professional Experience

During his academic journey, Akash Vikal gained industrial exposure through internship training at HIS Pharmaceuticals Pvt. Ltd., where he developed practical knowledge related to pharmaceutical manufacturing and formulation processes. He has also actively contributed to scientific communication and peer-review activities, including reviewing submissions for reputed journals such as Dovepress journals Clinical Ophthalmology and Eye and Brain. In addition, he delivered an academic webinar on scientific writing and publication strategies for researchers and healthcare professionals.

Research Interest

He has contributed extensively to pharmaceutical and biomedical research through numerous publications in reputed international journals. His research covers areas such as metal-organic frameworks in drug delivery, PROTAC-based cancer therapy, nanoparticle-mediated antimicrobial strategies, CRISPR-assisted nanotechnology, nanocarrier systems for ocular therapeutics, and phytoconstituent-based anticancer therapies. Several of his works have been published in recognized journals including Applied Materials Today, Drug Delivery and Translational Research, AAPS PharmSciTech, Current Pharmaceutical Design, and Experimental Eye Research.

Award and Honor

Akash Vikal has received recognition for his academic and scientific contributions through participation in national and international conferences, workshops, and faculty development programs. He earned a Certificate of Excellence in Peer Reviewing for his contribution to academic quality enhancement. His involvement in intellectual property awareness programs, pharmaceutical research conferences, and specialized training workshops reflects his commitment to continuous professional development and scientific advancement.

Conclusion

Mebratu Tafesse Teferi demonstrates strong potential for the Best Researcher Award. His substantial academic qualifications, leadership experience, and dedication to educational research are commendable. His publications reflect significant contributions to Ethiopian education and leadership studies, making him a valuable candidate for the award. To further enhance his candidacy, Mebratu could focus on broadening his research scope, fostering international collaborations, and increasing his publication reach in globally recognized journals.

Publications Top Noted

  • Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies
    Authors: Akash Vikal, Rashmi Maurya, Pradeep Kumar, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • Liposomal Paclitaxel in Breast Cancer Therapy: Advances, Clinical Insights, and Future Perspectives
    Authors: Akash Vikal, Rashmi Maurya, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • A Mini-Review on Unlocking Cognitive Enhancement: An Innovative Strategy for Optimal Brain Functions
    Authors: Akash Vikal, Rashmi Maurya, Brij Bihari Patel, Preeti Patel, Manish Kumar, Balak Das Kurmi
    Year: 2025
  • Andrographis paniculata in Fatty Liver Disease: Mechanisms, Nanocarrier Approaches, and Therapeutic Potential
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Development of Mucopenetrating Pegylated Liposomes Functionalized with Sodium Taurocholate for Enhanced Oral Insulin Delivery
    Authors: Akash Vikal, Rashmi Maurya, Balak Das Kurmi, S. Jindal, R. K. Narang
    Year: 2025
  • From Resistance to Response: Metallic Nanoparticles as Game Changers in Triple Negative Breast Cancer Therapy
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, R. K. Narang, Balak Das Kurmi
    Year: 2025
  • Lutein as a Liver Guardian: Insights into its Hepatoprotective Mechanisms, Bioavailability, and Emerging Therapeutic Roles
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Nanoemulsion Technology in Oral Drug Delivery: A Path to Enhanced Solubility and Bioavailability
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Role of dePEGylation in Vesicular Carriers-Mediated Stimuli-Responsive Drug Delivery to Tumors
    Authors: Akash Vikal, Rashmi Maurya, Abhinav Vashishat, Taqdir Singh, Satyam Khare, Preeti Patel, Balak Das Kurmi
    Year: 2025

 

Nikhilkumar Sakle | Anticancer | Research Excellence Award

Published-on by Indian Scientist

Dr. Nikhilkumar Sakle | Anticancer | Research Excellence Award

Y. B. Chavan College of Pharmacy, India

Dr. Nikhilkumar Sakle is a distinguished pharmaceutical scientist specializing in pharmacology and translational drug research. He holds advanced degrees in pharmacy and has extensive academic and teaching experience. His research focuses on anticancer therapeutics, network pharmacology, and bioactive compounds from medicinal plants. With numerous high-impact publications, patents, and funded research projects, he has earned prestigious academic awards for excellence in research and innovation. He is committed to advancing pharmaceutical sciences through impactful research, mentoring, and the development of novel therapeutic strategies for complex diseases.

Citation Metrics (Scopus)

350
250
30
20
0

Citations
330

Documents
27

h-index
11

Citations

Documents

h-index

Featured Publications

Bijesh Biswal | Cell Biology | Excellence in Research Award

Published-on by Indian Scientist

Dr. Bijesh Biswal | Cell Biology | Excellence in Research Award

National Institute of Technology Rourkela | India

Dr. Bijesh Kumar Biswal is an Associate Professor at the Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology Rourkela, India. He holds a Ph.D. in Cancer Biology from IIT Madras and has completed postdoctoral research at Rutgers University and Dartmouth College, USA. His research focuses on cancer biology, particularly transcriptional regulation, drug resistance mechanisms, and exosome-mediated drug delivery. Dr. Biswal has authored over 60 publications and has been cited more than 1,100 times, reflecting his significant contribution to the field. He has mentored 3 Ph.D. students and 15 Master’s students, with several ongoing research projects. His work has been recognized with awards such as the Best Faculty Advisor Award from NIT Rourkela and the Early Career Research Award from SERB, DST, New Delhi. Dr. Biswal is a life member of the Indian Association of Cancer Research and the Society of Biochemists India. His research continues to influence cancer therapeutics and drug resistance studies.

Profiles: Google Scholar | Orcid

Featured Publication

Tripathi, S. K., Panda, M., & Biswal, B. K. (2019). Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy. Food and Chemical Toxicology, 125, 566–582.

Tripathi, S. K., & Biswal, B. K. (2020). Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent. Pharmacological Research, 156, 104772.

Panda, M., Tripathi, S. K., & Biswal, B. K. (2021). SOX9: An emerging driving factor from cancer progression to drug resistance. Biochimica et Biophysica Acta (BBA) – Reviews on Cancer, 1875(2), 188517.

Panda, M., & Biswal, B. K. (2019). Cell signaling and cancer: A mechanistic insight into drug resistance. Molecular Biology Reports, 46(5), 5645–5659.

Mao, P., Hever-Jardine, M. P., Rahme, G. J., Yang, E., Tam, J., Kodali, A., Biswal, B., … (2013). Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma. PLoS One, 8(11), e81803.